A Phase I, Placebo Controlled, Randomised, Double Blind Two-Way Crossover Study to Investigate the Dose Response and Efficacy of Single and Repeat Doses of GW842166 in Healthy Volunteers Using Pharmacodynamic Pain Assessments

Trial Profile

A Phase I, Placebo Controlled, Randomised, Double Blind Two-Way Crossover Study to Investigate the Dose Response and Efficacy of Single and Repeat Doses of GW842166 in Healthy Volunteers Using Pharmacodynamic Pain Assessments

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 19 Feb 2015

At a glance

  • Drugs GW 842166X (Primary)
  • Indications Dental pain; Musculoskeletal pain
  • Focus Pharmacodynamics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 14 Dec 2014 Status changed from discontinued to withdrawn prior to enrolment, as reported by ClinicalTrials.gov.
    • 12 Jun 2008 Status changed from initiated to discontinued as reported by ClinicalTrials.gov.
    • 29 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top